| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |